WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India

Alternative livelihood training programme for rural women who are employed in the tobacco industry in India

ESMO and WCLC: Latest developments in EGFR mutated NSCLC

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients

Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Amivantamab-lazertinib continue to show benefit as a first-line standard-of-care for EGFR-mutated advanced NSCLC